CJJD [CHINA JO-JO DRUGSTORES] 8-K: (Original Filing)
[]
CJJD [CHINA JO-JO DRUGSTORES] 8-K: China Jo-Jo Drugstores Reports Third Quarter 2020 Financial
[China Jo-Jo Drugstores Reports Third Quarter 2020 Financial Results HANGZHOU, China, February 14, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer and wholesale distributor of pharmaceutical and other health]
CJJD [CHINA JO-JO DRUGSTORES] 10-Q: (Original Filing)
[] [CERTIFICATION I, Lei Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in ]
CJJD [CHINA JO-JO DRUGSTORES] 10-Q:
[] [CERTIFICATION I, Lei Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in ]
CJJD [CHINA JO-JO DRUGSTORES] 8-K: (Original Filing)
[China Jo-Jo Drugstores Reports Third Quarter 2020 Financial Results HANGZHOU, China, February 14, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer and wholesale distributor of pharmaceutical and other health]
CJJD [CHINA JO-JO DRUGSTORES] SC 13G/A: (Original Filing)
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed t]
CJJD [CHINA JO-JO DRUGSTORES] SC 13G/A: reporting person’s initial filing on this form with
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed t]
